IRF3 and non-small cell lung carcinoma: To further confirm the activation of the DNA sensing pathways induced by metformin treatment in LKB1 mutant NSCLC cells, we conducted IF staining to assess the subcellular translocation of activated p-IRF3 to the nucleus, where it promotes the transcription of IFN genes.